New Delhi: Amid the unprecedented COVID-19 crisis in India, the United States government will redirect from its own supplies 20 million doses of AstraZeneca vaccines. Over the weekend, the US announced that it will be diverting raw material to India for manufacturing of COVID-19 vaccines in the country. The development comes days after the US said that it will make available 60 million doses of AstraZeneca covid vaccine to other countries within 2 months. But despite no authorization yet, the country still has stockpiled the vaccine doses as part of its strategy to be ready for a range of scenarios. A White House fact sheet said, "Just as India sent assistance to the United States when our hospitals were strained early in the pandemic, the United States is determined to help India in its time of need."

Source: dna April 29, 2021 11:29 UTC